You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T/NK-lymphoproliferative disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

Recruiting
  • Hodgkin Disease
  • +5 more
  • MABEL CTLs
  • +2 more
  • Houston, Texas
  • +1 more
Jan 13, 2023

T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

Recruiting
  • T-cell Lymphoma
  • +30 more
  • Optional Blood Sample
  • Optional Nail Sample
  • Duarte, California
  • +25 more
Jul 28, 2023

LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

Recruiting
  • LGLL - Large Granular Lymphocytic Leukemia
  • +13 more
  • Duarte, California
  • +9 more
Aug 9, 2022

Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T

Recruiting
  • Hodgkin's Disease
  • +3 more
  • EBV-specific T cells: A
  • EBV-specific T cells: B
  • Houston, Texas
  • +1 more
Jun 28, 2022

Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,

Recruiting
  • Lymphoproliferative Disorders
  • +4 more
  • Immunosuppression Only Conditioning
  • +3 more
  • Bethesda, Maryland
  • +1 more
Jan 25, 2023

EBV-Related Hodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Non-Hodgkin's Lymphoma Trial in Houston (Dose Level 1A:

Not yet recruiting
  • EBV-Related Hodgkin Lymphoma
  • +2 more
  • Dose Level 1A: 2 x 10^7 cells/m2
  • +4 more
  • Houston, Texas
  • +1 more
Feb 7, 2022

EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm

Not yet recruiting
  • EBV Lymphoma
  • Post-transplant Lymphoproliferative Disease (PTLD)
  • Donor-derived ex-vivo expanded EBV Tscm CTL
  • Basel, Switzerland
  • +7 more
Jan 25, 2023

Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +23 more
  • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases Trial in Chapel Hill (ATLCAR.CD30 cells)

Recruiting
  • Lymphoma
  • +7 more
  • ATLCAR.CD30 cells
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022

Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,

Recruiting
  • Primary T-cell Immunodeficiency Disorders
  • +4 more
  • Immunosuppression Only Conditioning -Closed with amendment L
  • +4 more
  • Bethesda, Maryland
  • +1 more
Jul 26, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,

Recruiting
  • Lymphoproliferative Disorders
  • +4 more
  • Busulfan test dose
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +18 more
  • Scottsdale, Arizona
  • +1 more
Sep 28, 2020

Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • iCaspase9-transduced T cells
  • AP1903
  • Houston, Texas
  • +1 more
Jul 22, 2022

Recurrent Anaplastic Large Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Classic Hodgkin Lymphoma Trial in

Recruiting
  • Recurrent Anaplastic Large Cell Lymphoma
  • +9 more
  • Anti-CD30/CD16A Monoclonal Antibody AFM13
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 cells)

Active, not recruiting
  • Hodgkin Disease
  • +8 more
  • ATLCAR.CD30 cells
  • Chapel Hill, North Carolina
  • +1 more
Mar 2, 2022

Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

Terminated
Has Results
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
Aug 30, 2021

Epstein-Barr Virus Associated Lymphoproliferative Disorder, EBV-Related PTLD, EBV Related Non-Hodgkin's Lymphoma Trial in

Recruiting
  • Epstein-Barr Virus Associated Lymphoproliferative Disorder
  • +7 more
  • Nanatinostat in combination with valganciclovir
  • Birmingham, Alabama
  • +57 more
Aug 10, 2022

NonHodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Lymphoma Trial in Houston (EBVST Cells, Nivolumab)

Completed
  • NonHodgkin Lymphoma
  • +6 more
  • EBVST Cells
  • Nivolumab
  • Houston, Texas
  • +1 more
Jul 19, 2021

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

    Active, not recruiting
    • Adult Lymphocyte Depletion Hodgkin Lymphoma
    • +16 more
    • 6,8-bis(benzylthio)octanoic acid
    • bendamustine hydrochloride
    • Winston-Salem, North Carolina
    • +1 more
    Apr 8, 2022

    Extranodal NK/T-cell Lymphoma Trial in Korea, Republic of (VT-EBV-N, Placebo)

    Recruiting
    • Extranodal NK/T-cell Lymphoma
    • VT-EBV-N
    • Placebo
    • Busan, Korea, Republic of
    • +7 more
    Apr 28, 2022

    Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

    Recruiting
    • Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
    • +4 more
    • tabelecleucel
    • Duarte, California
    • +70 more
    Jun 23, 2022

    Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

    Recruiting
    • Extranodal NK T Cell Lymphoma
    • NK-Cell Leukemia
    • Anti-CD56 CAR T
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Jul 10, 2023